The use of benralizumab in the treatment of near fatal asthma: a new approach

Ítems similars

• Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
  per: Moran, AM, et al.
  Publicat: (2020)
• Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
  per: Moran, A, et al.
  Publicat: (2020)
• The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
  per: Russell REK, et al.
  Publicat: (2019-05-01)
• Reductions in Eosinophil Biomarkers by Benralizumab in Patients With Asthma
  per: Mirhojjat Khorasanizadeh, et al.
  Publicat: (2017-07-01)
• Effectiveness of Switching to Benralizumab in Severe Refractory Eosinophilic Asthma
  per: Gómez-Bastero Fernández A, et al.
  Publicat: (2022-05-01)